Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

Market Cap	4.40B +52.3%
Revenue (ttm)	336.73M +22.0%
Net Income	101.91M +49.3%
EPS	1.54 +47.4%
Shares Out	66.70M
PE Ratio	42.81
Forward PE	n/a
Dividend	0.60 (0.87%)
Ex-Dividend Date	May 30, 2025

Volume	1,173,156
Average Volume	1,172,551
Open	67.62
Previous Close	68.94
Day's Range	65.22 - 67.68
52-Week Range	41.40 - 92.50
Beta	-0.02
RSI	36.21
Earnings Date	Apr 28, 2026

About SHE:301033

Medprin Regenerative Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical devices. The company offers artificial dura matermembrane patches, craniomaxillofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also offers ReDura, a Synthetic Dural Substitute; NeoDura, a novel dural patch; Recranio, a Cranio-Maxillofacial repair system; and StypCel, an Absorbable Hemostat; Immiseal,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 337
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301033

Financial Performance

In 2024, SHE:301033's revenue was 278.44 million, an increase of 20.61% compared to the previous year's 230.87 million. Earnings were 78.85 million, an increase of 92.90%.